Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07590219 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Use of Liraglutide in Children Aged 6 to 12 Years With Severe Obesity

Name: Use of Liraglutide in Children Aged 6 to 12 Years With Severe Obesity — clinical trial record (NCT07590219)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusActive, Not Recruiting

PhasePhase 4

SponsorUniversity of Sao Paulo General Hospital

Started2024-03-30

View on ClinicalTrials.gov ↗

University of Sao Paulo General Hospital

109 trials monitored

See 2 trials at risk

Obesity

3,523 trials monitored

See 133 trials at risk

This randomized controlled trial evaluates the efficacy, safety, metabolic, and cardiovascular effects of liraglutide in children aged 6 to 12 years with severe obesity. Participants are randomized to receive liraglutide plus lifestyle intervention or lifestyle intervention alone for 6 months. In addition to primary outcomes related to weight loss and metabolic improvement, a predefined subgroup analysis evaluates cardiovascular function in participants receiving liraglutide using advanced echocardiographic techniques, including speckle-tracking-derived myocardial deformation parameters.

Trial Details

NCT Number	NCT07590219
Lead Sponsor	University of Sao Paulo General Hospital
Conditions	Severe Obesity, Cardiovascular Function, Liraglutide, Childhood Obesity, Echocardiography, Speckle Tracking
Enrollment	30 participants
Start Date	2024-03-30
Primary Completion	2027-04 (estimated)
Study Completion	2028-04 (estimated)
Updated on ClinicalTrials.gov	2026-05-15